HLA and susceptibility to two distinct types of drug-induced cutaneous reactions

European Journal of Dermatology

Volumn 7, Issue 5, 1997, Pages 329-332

  Drouet, Mireille ^a   Lizeaux Parneix, Véronique ^a   Miossec, Véronique ^a   Le Brun, Valéry ^a   Cogne, Michel ^a   Bonnetblanc, Jean Marie ^a   Bernard, Philippe ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Acute generalized exanthematous pustulosis; Cutaneous drug reaction; HLA; Maculopapular rash

Indexed keywords

ALLOPURINOL; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; BEZAFIBRATE; CEFADROXIL; CEFTRIAXONE; COTRIMOXAZOLE; FUROSEMIDE; HLA ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; IMIPENEM; JOSAMYCIN; LEUCINE; PENICILLIN G; PRAZEPAM; PRISTINAMYCIN; ROXITHROMYCIN; SPIRAMYCIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG ERUPTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; PAPULAR SKIN DISEASE; PHENOTYPE; PUSTULOSIS PALMOPLANTARIS; RASH; SKIN ALLERGY;

EID: 0030837126     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Alanko K, Stubb S, Kauppinen K. Cutaneous drug reactions: clinical types and causative agents. Acta Derm Venereol 1989; 69: 223-6.
2. Zürcher K, Krebs A. Cutaneous drug reactions. 2nd ed. Basel: Karger, 1992; 11-29.
3. Chosidow O, Bourguault I, Roujeau JC. Drug Rashes. What are the targets of cell mediated cytotoxicity? Arch Dermatol 1994; 290: 1176-8.
4. Roujeau JC, Bioulac-Sage P, Bourseau C, Guillaume JC, Bernard P, Lok C, Plantin P, Claudy A, Delavierre C, Vaillant L, Wechsler J, Danan G, Bénichon C, Beylot C. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 1991; 127: 1333-8.
5. Olerup O, Zetterqist H. HLA-DR typing by PCR amplification with sequence-specific primer (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-35.
6. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1991; 41: 119-34.
7. Haldane JBS. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1956; 20: 309-11.
8. Tsuji K, Aizawa M, Sasazuki T. HLA 1991. Proceedings of the eleventh international histocompatibility workshop and conference. Oxford: Science Publications, 1992; 1202.
9. Chan SH, Tan t, Wee GB, Lim AY. HLA and antibiotic allergic skin eruption. Ann Acad Med Singapore 1988; 17: 518-9.
10. Roujeau JC, Huynh T, Bracq C, Guillaume JC, Revuz J, Touraine R. Genetic susceptibility to toxic epidermal necrolysis. Arch Dermatol 1987; 123: 1171-3.
11. Mondino BJ, Brown SI, Rabin B. HLA antigens in Stevens-Johnson syndrome with ocular involvement. Arch Ophtalmol 1982; 100: 1453-4.
12. Paquet P, Nikkels A, Arrese JE, Vanderkelen A, Pietard GE. Macrophages and tumor necrosis factor in toxic epidermal necrolysis. Arch Dermatol 1994; 130: 605-8.
13. Klemola E. Hypersensitivity reactions to ampicillin in cytomegalovirus mononucleosis. Scand J Infect Dis 1970; 2: 29-31.
14. Shear NH, Spielberq SP, Grant DM, Tang BK, Kalow W. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med 1986; 105: 179-84.